News

15 Sep 2020

Swiss Health study – pilot phase started

Switzerland is launching the “Swiss Health study – pilot phase” to assess the feasibility of a nationwide human biomonitoring (HBM) project ...


7 Sep 2020

SCAHT is looking for a Research Coordinator (50% / up to 100%), closing date for applications is 4 October 2020

We are looking for a Research Coordinator who will work closely with experts at our partner institutions for the success of our 2021-2024 research programme ...


22 Jul 2020

OECD Health Effects Test Guidelines revised

On 26 June 2020, OECD adopted eight updated or corrected Test Guidelines for chemicals safety testing, used by OECD members and countries ...


22 Jul 2020

Retinoid AOP funding - call for tender by the Belgian REACH Competent authority, deadline 11 September 2020

A call for tender has been launched by the Belgian REACH Competent authority for the development of AOPs on the retinoid pathway ...


1 Jul 2020

Bericht des Bundesrats zu Aluminium in Antitranspiranten verabschiedet - SCAHT führte vertiefte Recherche durch

Der Bundesrat ist der Meinung, dass der heutige Gesetzesrahmen für die Verwendung von Aluminium in Antitranspiranten für den Schutz der Gesundheit der Bevölkerung ausreichend ist ...


25 Jun 2020

Coming: Symposium organised by UFT and SCAHT "Bridging the gap between regulation and research in human health effects of pesticides", webinar on 23 September 2020

At this one-day symposium we would like to paint a picture of the status quo on pesticide exposure and hazard assessment by inviting the leading Swiss experts from the research-, regulatory and industry communities ...


3 Jun 2020

The MAS in Toxicology 2020 (Geneva/Lausanne) is now open for registration - New deadline: 31 July 2020

The only part-time curriculum in Toxicology in Switzerland compatible with the needs of scientists already in employment ...


11 May 2020

SCAHT & COVID-19: In case of general inquiries or messages please send an email to info@scaht.org.

While the unprecedented public health emergency resulting from COVID-19 continues to evolve, SCAHT is affected in the same way as any other academic institution. Our top priority is of course the health and well-being of our staff and their families. Like everyone else, we are doing our best to continue working under difficult circumstances ...


10 May 2020

Pesticides: first cumulative risk reports published by EFSA

EFSA has published the results of its two pilot assessments on the risks posed to humans by residues of multiple pesticides in food ...


23 Apr 2020

Possible coronavirus drug - Team of Prof. Jörg Huwyler, University of Basel, produces generic medication

Hydroxychloroquine has anti-inflammatory, immunomodulatory, and antiviral effects and is used, inter alia, for the treatment of chronic rheumatic diseases. There are hopes that the drug might have a positive effect on the treatment of Covid-19 ...